导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 42.58% | 149/722 |
| 近一周 | -4.84% | 764/774 |
| 近一月 | -8.51% | 737/772 |
| 近一季 | -15.15% | 752/768 |
| 近半年 | 0.02% | 684/753 |
| 近一年 | 35.35% | 195/721 |
| 近两年 | 29.76% | 384/665 |
| 近三年 | 30.73% | 162/596 |
| 成立以来 | -17.22% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
15.80% 47/1014 |
15.18% 37/1038 |
22.47% 524/1050 |
- - |
| 2024 | -9.78% 764/1011 |
-8.94% 738/960 |
-2.82% 495/983 |
21.54% 45/991 |
-16.11% 982/1011 |
| 2023 | -1.16% 119/952 |
-1.55% 687/880 |
-5.79% 568/895 |
1.28% 52/915 |
5.22% 20/952 |
| 2022 | -15.17% 179/867 |
-21.49% 604/773 |
5.90% 464/806 |
-17.62% 693/845 |
23.85% 4/867 |
| 2021 | -23.91% 536/740 |
-4.39% 319/580 |
23.00% 115/659 |
-23.10% 652/704 |
-15.86% 687/740 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 易方达医药生物股票A VS. () |